BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 7480965)

  • 1. Acute effects of alpha-1 adrenoceptor antagonist, doxazosin on circulating vasoactive hormones.
    Veglio F; Schiavone D; Rossi A; Chiandussi L
    Riv Eur Sci Med Farmacol; 1994; 16(3-4):85-90. PubMed ID: 7480965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Add-on effect of bedtime dosing of the alpha(1)-adrenergic receptor antagonist doxazosin on morning hypertension and left ventricular hypertrophy in patients undergoing long-term amlodipine monotherapy.
    Ikeda T; Gomi T; Shibuya Y; Shinozaki S; Suzuki Y; Matsuda N
    Hypertens Res; 2007 Nov; 30(11):1097-105. PubMed ID: 18250559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute effects of doxazosin and atenolol on smoking-induced peripheral vasoconstriction in hypertensive habitual smokers.
    Lecerof H; Bornmyr S; Lilja B; De Pedis G; Hulthén UL
    J Hypertens Suppl; 1990 Sep; 8(5):S29-33. PubMed ID: 1981074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic alpha-1-adrenergic blockade increases sympathoneural but not adrenomedullary activity in patients with essential hypertension.
    Jacobs MC; Lenders JW; Willemsen JJ; Thien T
    J Hypertens; 1995 Dec; 13(12 Pt 2):1837-41. PubMed ID: 8903663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodynamic interaction between a daily dosed phosphodiesterase 5 inhibitor, tadalafil, and the alpha-adrenergic blockers, doxazosin and tamsulosin, in middle-aged healthy male subjects.
    Guillaume M; Lonsdale F; Darstein C; Jimenez MC; Mitchell MI
    J Clin Pharmacol; 2007 Oct; 47(10):1303-10. PubMed ID: 17906163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anoikis induction by quinazoline based alpha 1-adrenoceptor antagonists in prostate cancer cells: antagonistic effect of bcl-2.
    Keledjian K; Kyprianou N
    J Urol; 2003 Mar; 169(3):1150-6. PubMed ID: 12576871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo administration of doxazosin in rats highly decreases serum circulating levels of testosterone through a mechanism involving the testicular renin-angiotensin system.
    de la Chica-Rodríguez S; Cortés-Denia P; Ramírez-Expósito MJ; de Saavedra JM; Sánchez-Agesta R; Pérez Mdel C; Martínez-Martos JM
    Int J Androl; 2008 Jun; 31(3):364-70. PubMed ID: 17573849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Profile of doxazosin in patients with benign prostatic hyperplasia.
    Janknegt RA
    Scand J Urol Nephrol Suppl; 1995; 168():21-7. PubMed ID: 7541548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum lipid changes on low salt diet. Effects of alpha 1-adrenergic blockade.
    Fliser D; Nowack R; Allendorf-Ostwald N; Kohl B; Hübinger A; Ritz E
    Am J Hypertens; 1993 Apr; 6(4):320-4. PubMed ID: 8099492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of selective alfa 1 and beta 1-adrenoreceptor blockade on lipoprotein and carbohydrate metabolism in hypertensive subjects, with special emphasis on insulin sensitivity.
    Andersson PE; Johansson J; Berne C; Lithell H
    J Hum Hypertens; 1994 Mar; 8(3):219-26. PubMed ID: 8006923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of acute administration of doxazosin on fasting and postprandial haemodynamics and lipid metabolism in healthy subjects.
    Ulahannan TJ; Karpe F; Humphreys SM; Matthews DR; Frayn KN
    Horm Metab Res; 2002 Sep; 34(9):499-503. PubMed ID: 12384826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Doxazosin treatment causes differential alterations of alpha 1-adrenoceptor subtypes in the rat kidney, heart and aorta.
    Yono M; Foster HE; Shin D; Takahashi W; Pouresmail M; Latifpour J
    Life Sci; 2004 Oct; 75(21):2605-14. PubMed ID: 15363664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of doxazosin on ambulatory blood pressure and sympathetic nervous activity in hypertensive Type 2 diabetic patients with overt nephropathy.
    Yasuda G; Hasegawa K; Kuji T; Ogawa N; Shimura G; Umemura S; Tochikubo O
    Diabet Med; 2005 Oct; 22(10):1394-400. PubMed ID: 16176202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
    Pessina AC; Ciccariello L; Perrone F; Stoico V; Gussoni G; Scotti A; Muggeo M
    Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative alpha-1 adrenoceptor subtype selectivity and functional uroselectivity of alpha-1 adrenoceptor antagonists.
    Martin DJ; Lluel P; Guillot E; Coste A; Jammes D; Angel I
    J Pharmacol Exp Ther; 1997 Jul; 282(1):228-35. PubMed ID: 9223558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Doxazosin for the treatment of benign prostatic hyperplasia in patients with mild to moderate essential hypertension: a double-blind, placebo-controlled, dose-response multicenter study.
    Gillenwater JY; Conn RL; Chrysant SG; Roy J; Gaffney M; Ice K; Dias N
    J Urol; 1995 Jul; 154(1):110-15. PubMed ID: 7539854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth inhibitory effect of doxazosin on prostate and bladder cancer cells. Is the serotonin receptor pathway involved?
    Siddiqui EJ; Shabbir M; Thompson CS; Mumtaz FH; Mikhailidis DP
    Anticancer Res; 2005; 25(6B):4281-6. PubMed ID: 16309229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of alpha1-adrenergic receptor blockade by doxazosin on renin-angiotensin system-regulating aminopeptidase and vasopressin-degrading activities in male and female rat thalamus.
    de la Chica-Rodríguez S; Cortés-Denia P; Ramírez-Expósito MJ; Martínez-Martos JM
    Horm Metab Res; 2007 Nov; 39(11):813-7. PubMed ID: 17992636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Doxazosin GITS versus standard doxazosin in mild to moderate hypertension.
    Calvo C; Gil-Extremera B; Gomez-Fernández P; Masramon X; Pueyo C; Armada B
    Int J Cardiol; 2005 May; 101(1):97-104. PubMed ID: 15860390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Doxazosin and hydrochlorothiazide equally affect arterial wall thickness in hypertensive males with hypercholesterolaemia (the DAPHNE study). Doxazosin Atherosclerosis Progression Study in Hypertensives in the Netherlands.
    Hoogerbrugge N; de Groot E; de Heide LH; de Ridder MA; Birkenhägeri JC; Stijnen T; Jansen H
    Neth J Med; 2002 Oct; 60(9):354-61. PubMed ID: 12572707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.